Number of Shares
65,897.00
Current Holdings Value*
$4.58 Mil
% of Portfolio
1.05%
Total Estimate Gain
$-1.00 Mil
% of Total Estimate Gain
-17.39%

M. Kulyk & Associates, LLC's Novo Nordisk AS Holding Summary

As of 2025-03-31, M. Kulyk & Associates, LLC held 65,897.00 shares of Novo Nordisk AS(NVO), totaling $4.58 Mil. This investment constitutes 1.05% of their stock portfolio, and M. Kulyk & Associates, LLC now holds 0% of the outstanding Novo Nordisk AS(NVO) stock.

The initial trade took place in 2023Q4. And since then M. Kulyk & Associates, LLC has made 3 purchases of NVO, at an average price of $84.02, for a total of 68,694.00 shares. In addition, there have been 3 sales at an average price of $131.43 for 2,797.00 shares. Based on historical transaction data and NVO's current price of $66.78, M. Kulyk & Associates, LLC's estimated gain on his NVO holdings is $-1.00 Mil, reflecting a -17.39% gain to date.

M. Kulyk & Associates, LLC NVO ($66.78) Holding Chart

M. Kulyk & Associates, LLC NVO ($66.78) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1